Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporin A in Patients With Left Ventricular Hypertrophy Caused by Sarcomeric Gene Mutations
NCT00001965Phase 2Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Dec 1999
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclosporine in hypertrophic cardiomyopathy (HCM), sponsored by National Heart, Lung, and Blood Institute. Started Dec 1999; status: completed.
02
Drugs
cyclosporine
03
Conditions
hypertrophic cardiomyopathy (HCM)
Beyond the preview
Go deeper on NCT00001965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001965.